These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22940840)

  • 1. Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients.
    Nascimbeni AC; Fanin M; Masiero E; Angelini C; Sandri M
    Autophagy; 2012 Nov; 8(11):1697-700. PubMed ID: 22940840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII).
    Nascimbeni AC; Fanin M; Masiero E; Angelini C; Sandri M
    Cell Death Differ; 2012 Oct; 19(10):1698-708. PubMed ID: 22595755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.
    Douillard-Guilloux G; Raben N; Takikita S; Ferry A; Vignaud A; Guillet-Deniau I; Favier M; Thurberg BL; Roach PJ; Caillaud C; Richard E
    Hum Mol Genet; 2010 Feb; 19(4):684-96. PubMed ID: 19959526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.
    Takikita S; Myerowitz R; Zaal K; Raben N; Plotz PH
    Mol Genet Metab; 2009 Apr; 96(4):208-17. PubMed ID: 19167256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.
    Raben N; Baum R; Schreiner C; Takikita S; Mizushima N; Ralston E; Plotz P
    Autophagy; 2009 Jan; 5(1):111-3. PubMed ID: 19001870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Benefit of Autophagy Modulation in Pompe Disease.
    Lim JA; Sun B; Puertollano R; Raben N
    Mol Ther; 2018 Jul; 26(7):1783-1796. PubMed ID: 29804932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy.
    McCall AL; Stankov SG; Cowen G; Cloutier D; Zhang Z; Yang L; Clement N; Falk DJ; Byrne BJ
    Curr Gene Ther; 2019; 19(3):197-207. PubMed ID: 31223086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation.
    Shemesh A; Wang Y; Yang Y; Yang GS; Johnson DE; Backer JM; Pessin JE; Zong H
    Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1251-9. PubMed ID: 25231351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in skeletal muscle: implications for Pompe disease.
    Shea L; Raben N
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1(Suppl 1):S42-7. PubMed ID: 20040311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel autophagic vacuolar myopathies: Phenotype and genotype features.
    Napolitano F; Terracciano C; Bruno G; De Blasiis P; Lombardi L; Gialluisi A; Gianfrancesco F; De Giovanni D; Tummolo A; Di Iorio G; Limongelli G; Esposito T; Melone MAB; Sampaolo S
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):664-678. PubMed ID: 33393119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy dysregulation in Danon disease.
    Nascimbeni AC; Fanin M; Angelini C; Sandri M
    Cell Death Dis; 2017 Jan; 8(1):e2565. PubMed ID: 28102838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease.
    Raben N; Hill V; Shea L; Takikita S; Baum R; Mizushima N; Ralston E; Plotz P
    Hum Mol Genet; 2008 Dec; 17(24):3897-908. PubMed ID: 18782848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of Autophagy in Pompe Disease.
    Do H; Meena NK; Raben N
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease.
    Nishiyama Y; Shimada Y; Yokoi T; Kobayashi H; Higuchi T; Eto Y; Ida H; Ohashi T
    Mol Genet Metab; 2012 Nov; 107(3):490-5. PubMed ID: 23041259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease.
    Douillard-Guilloux G; Richard E; Batista L; Caillaud C
    J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle.
    Takikita S; Schreiner C; Baum R; Xie T; Ralston E; Plotz PH; Raben N
    PLoS One; 2010 Dec; 5(12):e15239. PubMed ID: 21179212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and lysosomes in Pompe disease.
    Fukuda T; Roberts A; Ahearn M; Zaal K; Ralston E; Plotz PH; Raben N
    Autophagy; 2006; 2(4):318-20. PubMed ID: 16874053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
    Koeberl DD; Luo X; Sun B; McVie-Wylie A; Dai J; Li S; Banugaria SG; Chen YT; Bali DS
    Mol Genet Metab; 2011 Jun; 103(2):107-12. PubMed ID: 21397538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe disease.
    Farah BL; Madden L; Li S; Nance S; Bird A; Bursac N; Yen PM; Young SP; Koeberl DD
    FASEB J; 2014 May; 28(5):2272-80. PubMed ID: 24448824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.